iPharmaCenter

Putting patients at center

  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
  • Home

  • COVID-19

  • News

  • Conferences

  • Healthcare Policies & Systems

  • Regional News

    • North America
    • Europe
    • APAC
  • Patient info

  • More

    Use tab to navigate through the menu items.
    COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

    COVID19 vaccine updates | News | Novovax | Janssen's COVID19 vaccine

    0
    COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

    COVID-19 India Updates | Covaxin approved for children | Vaccines for teenagers

    0
    European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

    European Commission approved Roche's and Celltrion's monoclonal antibodies for COVID19

    0
    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

    Despite facing criticism on handling the COVID19 situation, Tedros to continue as WHO chief

    0
    WHO granted EUL to Covaxin; acclaims easy storage requirement

    WHO granted EUL to Covaxin; acclaims easy storage requirement

    0
    United Kingdom COVID19 News | Has Britain reached herd immunity?

    United Kingdom COVID19 News | Has Britain reached herd immunity?

    0
    France COVID-19 Updates | COVID-19 News in Europe

    France COVID-19 Updates | COVID-19 News in Europe

    0
    Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

    Is AstraZeneca and Oxford’s COVID vaccine safe? Australia prefers Pfizer vaccine

    0
    European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

    European Commission to purchase 200 million doses of Johnson and Johnson's COVID 19 vaccine

    0
    J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

    J&J has initiated the Phase 3 clinical trial of the COVID-19 vaccine

    0
    Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

    Sanofi and GSK to supply 72 million doses of the COVID-19 vaccine

    0
    Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

    Oxford vaccine trials were paused because of safety concerns; AZ said it’s ‘routine’

    0
    FDA extended emergency use authorization of Veklury to all hospitalized patients

    FDA extended emergency use authorization of Veklury to all hospitalized patients

    0
    FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

    FDA has provided emergency use authorization for Abbott’s easy-to-use COVID-19 antigen test

    0
    CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

    CORONAVIRUS RECOMMENDATIONS FROM VARIOUS HEALTH AGENCIES

    0

    Gilead’s Veklury received conditional marketing authorization from the European Commission

    0

    Janssen’s COVID-19 vaccine trial to begin in second half of July

    0

    Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit

    0

    Gilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients

    0

    EMA allowed compassionate use of remdesivir to patients who were not on mechanical ventilation

    0

    PFIZER AND BIONTECH STARTS THE CLINICAL TRIALS OF COVID-19 VACCINE

    0
    FACTS ABOUT CHLOROQUINE TREATMENT FOR COVID-19

    FACTS ABOUT CHLOROQUINE TREATMENT FOR COVID-19

    0

    J&J announces lead vaccine for COVID-19, commits to provide one billion vaccines worldwide

    0
    NICE recommendation to manage symptoms of COVID-19

    NICE recommendation to manage symptoms of COVID-19

    0
    COVID-19 UPDATES

    COVID-19 UPDATES

    0
    HOW CHINA IS RESPONSIBLE FOR COVID-19 OUTBREAK

    HOW CHINA IS RESPONSIBLE FOR COVID-19 OUTBREAK

    0

    Please feel free to share your thoughts and comments. If you have questions, please comment, and we will try to get back with answers. If you liked the content, please share it on your network.

    For any further updates, contact us at ipharmaservices@gmail.com

    ©2022 by ipharmaservices